Optimal Asset Management Inc. raised its holdings in Agilent Technologies Inc (NYSE:A) by 36.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,067 shares of the medical research company’s stock after purchasing an additional 7,289 shares during the period. Optimal Asset Management Inc.’s holdings in Agilent Technologies were worth $1,939,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. NuWave Investment Management LLC grew its holdings in Agilent Technologies by 1,116.1% in the first quarter. NuWave Investment Management LLC now owns 377 shares of the medical research company’s stock valued at $27,000 after purchasing an additional 346 shares during the period. Ameritas Investment Company LLC boosted its stake in shares of Agilent Technologies by 169.1% in the first quarter. Ameritas Investment Company LLC now owns 444 shares of the medical research company’s stock worth $31,000 after acquiring an additional 279 shares during the last quarter. Sowa Financial Group Inc. boosted its stake in shares of Agilent Technologies by 1,425.0% in the first quarter. Sowa Financial Group Inc. now owns 488 shares of the medical research company’s stock worth $35,000 after acquiring an additional 456 shares during the last quarter. Valeo Financial Advisors LLC lifted its position in Agilent Technologies by 217.3% during the first quarter. Valeo Financial Advisors LLC now owns 476 shares of the medical research company’s stock worth $37,000 after buying an additional 326 shares in the last quarter. Finally, Column Capital Advisors LLC lifted its position in Agilent Technologies by 26.0% during the first quarter. Column Capital Advisors LLC now owns 606 shares of the medical research company’s stock worth $43,000 after buying an additional 125 shares in the last quarter.

A number of equities research analysts have commented on the company. Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating and set a $89.00 target price on the stock. in a research report on Friday, June 12th. SunTrust Banks lowered their target price on Agilent Technologies from $90.00 to $75.00 and set a “hold” rating for the company in a research note on Thursday, April 16th. Stifel Nicolaus lowered their price objective on Agilent Technologies from $85.00 to $73.00 and set a “hold” rating for the company in a research report on Thursday, April 2nd. Wells Fargo & Co boosted their target price on Agilent Technologies from $82.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, May 22nd. Finally, Cfra reduced their target price on Agilent Technologies from $89.00 to $85.00 and set a “hold” rating for the company in a report on Friday, May 22nd. Eleven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $85.75.

In related news, VP Rodney Gonsalves sold 4,566 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $85.30, for a total transaction of $389,479.80. Following the sale, the vice president now owns 102,806 shares of the company’s stock, valued at $8,769,351.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Michael R. Mcmullen sold 18,018 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $80.00, for a total value of $1,441,440.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 64,426 shares of company stock worth $5,300,943.

NYSE:A traded down $1.04 during mid-day trading on Friday, reaching $86.23. The stock had a trading volume of 166,589 shares, compared to its average volume of 1,747,852. The company has a market capitalization of $26.73 billion, a price-to-earnings ratio of 40.26, a price-to-earnings-growth ratio of 2.78 and a beta of 1.13. Agilent Technologies Inc has a 1-year low of $61.13 and a 1-year high of $93.04. The stock’s 50 day simple moving average is $85.55 and its two-hundred day simple moving average is $81.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.63 and a quick ratio of 1.24.

Agilent Technologies (NYSE:A) last issued its earnings results on Thursday, May 21st. The medical research company reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.10. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. Agilent Technologies’s quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.71 earnings per share. Sell-side analysts anticipate that Agilent Technologies Inc will post 3.11 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, June 29th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.84%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.15%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: How does a security become overbought?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.